In response to the FDA guidance document for Babesia, CTS will implement the licensed Grifols Babesia test for samples received on April 20, 2020 at the Charlotte, Dallas, Phoenix, St. Louis and Tampa laboratories. Be watching for details on an upcoming webinar that will provide you with an overview of implementing this testing.
Check out the Communication page for the complete details by clicking the link: Communications
CTS will be transitioning to a new sFTP server for clients who send test request and/or receive...
Reminder - Five CTS Forms will be updated on Monday September 2, 2019. Some of the forms are posted ...
IPFA welcomes Marion Lanteri as Executive Board member, CTS as new member organization
TEMPE, Ariz. (Sept. 8, 2022) — Marion Lanteri, Ph.D., began this week as Creative Testing Solu...
Josh Moon has been appointed Chief Operating Officer (COO) at Creative Testing Solutions (CTS), effe...
The COVID-19 pandemic has unveiled the huge challenges and risks health workers are facing globally ...